Wilson's disease;Enfermedad de Wilson

Gastroenterologia y Hepatologia

Volumn 29, Issue 1, 2006, Pages 29-33

  Bruguera, M ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CUPRIPEN; PENICILLAMINE; TRIENTINE; ZINC SULFATE;

ARTICLE; CLINICAL FEATURE; CUTIS LAXA; DIET; GOODPASTURE SYNDROME; HUMAN; HYPERSENSITIVITY REACTION; LIVER TOXICITY; MYASTHENIA GRAVIS; NEPHROTIC SYNDROME; OPTIC NEURITIS; PYRIDOXINE DEFICIENCY; SYSTEMIC LUPUS ERYTHEMATOSUS; WILSON DISEASE;

EID: 33644537423     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13083259     Document Type: Article

References (28)

1. El-Youssef M. Wilson disease. Mayo Clin Proc. 2003;78:1126-36.
2. Riordan SM, Williams R. The Wilson's disease gene and phenotypic diversity. J Hepatol. 2001;34:165-71.
3. Ferenci P. Review article: diagnosis and current therapy of Wilson's disease. Aliment Pharmacol Ther. 2004;19:157-65.
4. Roberts EA, Schilsky ML. AASLD practice guideline on Wilson disease. Hepatology. 20003;37:1475-92.
5. Pfeil SA, Lynn DJ. Wilson's disease: copper unfettered. J Clin Gastroenterol. 1999;29:22-31.
6. Ala A, Borjigin J, Rochwarger A, Schilsky M. Wilson disease in septuagenarian siblings: raising the bar for diagnosis. Hepatology. 2005;41:668-70.
7. Gow PJ, Smallwood RA, Angus PW, Smith AL, Wall AJ, Sewell RB. Diagnosis of Wilson's disease: an experience over three decades. Gut. 2000;46:415-9.
8. Steindl P, Ferenci P, Dienes HP, et al. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology. 1997;113:212-8.
9. Martins da Costa C, Baldwin D, Portmann B, Lohn Y, Mowat AP, Mieli-Vergani G. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease. Hepatology. 1992;15:609-15.
10. Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, et al. Diagnosis and phenotypic classification of Wilson disease. Liver. 2003;123:139-42.
11. Brewer Gj, Askari FK. Wilson's disease: clinical management and therapy. J Hepatol. 2005;42 Suppl 1:513-21.
12. Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine. 1992;71:139-64.
13. Brewer GJ, Terry CA, Aisen AM, Hill GM. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol. 1987;44:490-3.
14. Iorio R, D'Ambrosi M, Marcellini M, Barbera C, Maggiore G, Zancan L, et al. Serum transaminases in children with Wilson's disease. J Pediatr Gastroenterol Nutr. 2004;39:331-6.
15. Walshe JM. Dangers of non-compliance in Wilson's disease. Lancet. 1986;1:845-7.
16. Brewer GJ, Dick RD, Jonson VD, Brunberg JA, Kluin KJ, Fink JK. The treatment of Wilson's disease with cine. J Lab Clin Med. 1999;134:322-4.
17. Brewer GJ, Hill GM, Prasad AS, Cossack ZT, Rabbani P. Oral cine therapy for Wilson's disease. Ann Intern Med. 1983;99:314-9.
18. Shilsky ML, Shneider B. Trientine and cine combination therapy for the treatment of Wilson's disease. Hepatology. 2001;34:210A.
19. Dhawan A, Taylor RM, Cheeseman P, De Silva P, Katsiyiannakis L, Mieli-Vergani G. Wilson's disease in children: 37-year experience and revised King's score for liver transplantation. Liver Transplant. 2005;11:441-8.
20. Emre S, Atillasoy EO, Ozdemir S, et al. Orthotopic liver transplantation for Wilson's disease: a single centre experience. Liver Transpl. 2001;72:1232-6.
21. Sutclffe RP, Maguire DD, Muiesan P, Dhawan A, Mieli-Vergani G, O'Grady JG, et al. Liver transplantation for Wilson's disease: long term results and quality-of-life assessment. Transplantation. 2003;75:1003-6.
22. Bax RT, Hassler A, Luck W, et al. Cerebral manifestations of Wilson's disease successfully treated with liver transplantation. Neurology. 1998;51:863-5.
23. Ferenci P. Wilson's disease. En: Bacon BR, Di Bisceglie AM, editors. Liver Disease. Diagnosis and management. Philadelphia: Churchill Livingstone; 2000.
24. Durand F, Bernuau J, Giostra E, Mentha G, Shouval D, Degott C, et al. Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine. Gut. 2001;48:849-52.
25. Sen S, Felldin M, Steiner C, Larsson B, Gillett GT, Olausson M, et al. Albumin dialysis and molecular adsorbents recirculating system (MARS) for acute Wilson's disease. Liver Transpl. 2002;8:962-7.
26. Brewer GJ, Hedera P, Kluin KJ, Carlson M, Askari F, Dick RB, et al. Treatment of Wilson disease with ammonium tetrathiomolybdate. III. Initial therapy in a total of 55 neurologically affected patients and follow-up with cine therapy. Arch Neurol. 2003;60:379-85.
27. Brewer GJ, Johnson VD, Dick RD, Fink JK, Kluin KJ, Hedera P. Treatment of Wilson's disease with cine XVII. Treatment during pregnancy. Hepatology. 2000;31:364-70.
28. Solomon L, Abrams G, Dinner M, Berman JL. Neonatal abnormalities associated with D-penicillamine treatment during pregnancy. N Engl J Med. 1977;296:54-5.